| Sr. No. | Name of the project | Method of detection | Linearity Range | Submitted to |
| 1 | Abacavir | LC-MS/MS | 25.000 to 10000.000 ng/mL | US |
| 2 | Aceclofenac | LC-MS/MS | 99.688 to 29906.419 ng/mL | EXP |
| 3 | Acetazolamide | LC-MS/MS | 100.000 ng/mL to 20000.000 ng/mL | EXP |
| 4 | Acetylcysteine | LC-MS/MS | 75.000 ng/mLto 3000.000ng/mL | UK |
| 5 | Allopurinol | LC-MS/MS | 100.000 to 10000.000 ng/mL | EXP |
| 6 | Amlodipine | LC-MS/MS | 0.100 to 25.000 ng/mL | UK/DC |
| 7 | Amodiaquine | LC-MS/MS | For Amodiaquine: 2.000 to 100.000 ng/mL For Desethyl Amodiaquine: 10.000 to 1000.000ng/mL | WHO |
| 8 | Amodiaquine | LC-MS/MS | For Amodiaquine: 0.500 ng/mL to 100.000 ng/mL, For N-Desethyl Amodiaquine: 4.000 ng/mL to 800.000 ng/mL | WHO |
| 9 | Amoxicillin + Clavulanic Acid | LC-MS/MS | For Amoxicillin 99.618 ng/mL to 15019.784 ng/mL For Clavulanic Acid: 49.853 ng/mL to 2132.737 ng/mL | AN |
| 10 | Anagrelide | LC-MS/MS | 99.904 to 7530.417 ng/mL | US |
| 11 | Artemither and Lumefentrine | LC-MS/MS | For Artemether: 2.000 ng/mL to 250.000 ng/mL For Dihydroartemisinin: 2.000 ng/mL to 250.000 ng/mL | WHO |
| 12 | Artesunate | LC-MS/MS | For Artesunate: 2.000 to 100.000 ng/mL For Dihydroartimisinin: 5.000 to 500.000ng/mL | EXP/WHO |
| 15 | Atazanavir | LC-MS/MS | 10.133 to 5041.618 ng/mL | |
| 13 | Atazanavir | LC-MS/MS | 10.002 to 5000.853 ng/mL | |
| 14 | Atenolol | LC-MS/MS | 10.000 to 2000.000 ng/mL | US |
| 16 | Atorvastatin | LC-MS/MS | 0.500 to 50.000 ng/mL | |
| 17 | Azathioprine | LC-MS/MS | For Azathioprine: 2.000 to 200.000ng/mL For 6-Mercaptopurine: 2.000 to 2000.000ng/mL | US |
| 18 | Bicalutamide | LC-MS/MS | 10.020 to 601.200 ng/mL | AN/US |
| 19 | Bromocriptine | LC-MS/MS | 10.000 pg/mL to 505.000 pg/mL | US |
| 20 | Bromocriptine | LC-MS/MS | 10.112 to 503.582 pg/mL | US |
| 21 | Bupropion | LC-MS/MS | For Bupropion: 0.200 to 200.000ng/mL For Hydroxy Bupropion: 1.000 to 1000.000 ng/mL For Erythro/threo bupropion: 0.200 to 200.000 ng/mL | EXP |
| 22 | Buprenorphine | LC-MS/MS | For Buprinorphine: 0.102 ng/mL to 5.027 ng/mL For Buprinorphine: 0.101 ng/mL to 5.009 ng/mL | EM |
| 23 | Carbamazepine | LC-MS/MS | 50.000 ng/mL to 5000.000 ng/mL | UK |
| 24 | Carbimazole | LC-MS/MS | 10.000 ng/mL to 600.000 ng/mL | UK |
| 25 | Carvedilol | HPLC | 2.000 to 200.000 ng/mL | UK |
| 26 | Cetirizine | LC-MS/MS | 5.000 to 1000.000 ng/mL | EXP/UK/US |
| 27 | Ciprofloxacin | LC-MS/MS | 25.000ng/mL to 6000.000ng/mL | EXP/US |
| 28 | Citalopram | LC-MS/MS | 0.500ng/mL to 200.000ng/mL | US |
| 29 | Cinitapride | LC-MS/MS | 20.118 to 2011.797 pg/mL | DC |
| 30 | Clonidine | LC-MS/MS | 49.850 ng/mL to 2517.425 ng/mL | US |
| 31 | Cyclobenzaprine | LC-MS/MS | 0.150 ng/mL to 50.000 ng/mL | US |
| 32 | Cyclocerine | HPLC | 0.015 to 20.000 µg/mL | WHO |
| 33 | Diclofenac Sodium | LC-MS/MS | 10.014ng/mL to 3029.418ng/mL | US |
| 34 | Diclofenac Sodium | LC-MS/MS | 10.000 to 2000.000ng/mL | - |
| 35 | Dipyridamole | LC-MS/MS | 20.000 ng/mL to 4000.000 ng/mL | |
| 36 | Doxycycline | LC-MS/MS | 30.000 ng/mL to 3000.000 ng/mL | EXP |
| 37 | Efavirenz | LC-MS/MS | 50.000 to 6000.000ng/mL | US |
| 38 | Emtricitabine | LC-MS/MS | 50.451 ng/mL to 5045.087ng/mL | US |
| 39 | Enalapril & Enalaprilate | LC-MS/MS | For Enalapril: 0.500 to 200.000ng/mL For Enalaprilate: 1.000 to 200.000ng/mL | GCC/UK |
| 40 | Eperisone | LC-MS/MS | 0.050ng/mL to 20.000ng/mL | - |
| 41 | Ethionamide | HPLC | 50.000 to 8000.000 ng/mL | WHO |
| 42 | Felodipine | LC-MS/MS | 0.200 to 20.000 ng/mL | EXP |
| 43 | Felodipine | LC-MS/MS | 0.201 to 20.106 ng/mL | EXP/US |
| 44 | Finasteride | LC-MS/MS | 0.500 ng/mL to 100.000 ng/mL | EM/EXP/US |
| 45 | Fluconazole | LC-MS/MS | 25.000 ng/mLto 10000.000ng/mL | US |
| 46 | Fluoxetine | LC-MS/MS | For Fluoxetine: 0.500 to 100.000ng/mL For Norfluoxetine: 0.500 to 100.000 ng/mL | UK/US |
| 47 | Gabapentine | LC-MS/MS | 100.059 to 8004.758 ng/mL | US |
| 48 | Galantamine | LC-MS/MS | 5.000 ng/mL to 500.000 ng/mL | - |
| 49 | Glipizide | LC-MS/MS | 10.000 ng/mLto 2000.000ng/mL | EXP |
| 50 | Glipizide | LC-MS/MS | 10.000 ng/mL to 1600.000 ng/mL | EXP |
| 51 | Granisetrin | LC-MS/MS | 0.100 ng/mL to 20.033 ng/mL | US |
| 52 | Hydrochlorothiazide | LC-MS/MS | 5.000 to 500.000ng/mL | US |
| 53 | Hydrochlorothiazide + Losartan + Losartan Carboxy Acid | LC-MS/MS | For Hydrochlorothiazide: 4.795 to 504.710ng/Ml For Losartan: 9.981 to 1202.696 ng/mL For Losartan Carboxy Acid: 9.963 to 1200.516 ng/mL | AN/US |
| 54 | Ibuprofen | LC-MS/MS | 0.500 to 100.000µg/mL | CA/UK |
| 55 | Indomethacin | LC-MS/MS | 19.988 to 1202.295 ng/mL | |
| 56 | Indinavir | LC-MS/MS | 50.000 ng/mL to 10000.000 ng/mL | - |
| 57 | Lami + Stavi + Nevi | LC-MS/MS | For Lamivudine: 25.000 to 3000.000 ng/mL For Stavudine: 20.000 to 2000.000ng/mL For Nevirapine: 50.000 ng/mLto 5000.000 ng/mL | SA |
| 58 | Lamivudine | LC-MS/MS | 25.000 ng/mL to 3000.000 ng/mL | US |
| 59 | Lamivudine+Zidovudine | LC-MS/MS | 30.000 ng/mL to 3000.000 ng/mL | US/WHO |
| 60 | Levofloxacin | LC-MS/MS | 50.000 ng/mL to 20000.000ng/mL | EXP |
| 61 | Lopinavir & Ritonavir | LC-MS/MS | For Lopinavir: 50.000 to 20000.000 ng/mL For Ritonavir: 20.000 to 3000.000ng/mL | US |
| 62 | Loratidine+ Desloratidine | LC-MS/MS | 0.100 to 9.974 ng/mL | - |
| 63 | Losartan | LC-MS/MS | For first method: 25.000 to 500.000 ng/mL For second method: For Losartan: 5.000 to 2000ng/mL For Losartan Carboxy Acid: 5.000 to 2000.000ng/mL | - |
| 64 | Lovastatine | LC-MS/MS | For Lovastatin: 0.200 ng/mL to 50.000 ng/mL For Lovastatin Hydroxy Acid: 0.200 to 50.000ng/mL | EXP/US |
| 65 | Lumefantrine | LC-MS/MS | 100.000 ng/mL to 20000.000 ng/mL | WHO |
| 66 | Meloxicam | LC-MS/MS | 10.000 to 5000.000ng/mL | US/EXP |
| 67 | Metformin & Glipizide | LC-MS/MS | For Metformin: 20.000 to 2000.000 ng/mL For Glipizide: 5.000 to 2000.000 ng/mL | US |
| 68 | Metformin + Glimepiride | LC-MS/MS | For Metformin: 0.200 ng/mL to 50.000 ng/mL For Glimepiride: 0.200 to 50.000ng/mL | DC |
| 69 | Metformin + Glyburide | LC-MS/MS | For Metformin: 20.000 ng/mL to 1500.000 ng/mL For Glyburide: 5.000 to 500.000ng/mL | US |
| 70 | Metoclopramide | LC-MS/MS | 0.500 ng/mL to 50.000 ng/mL | US |
| 71 | Minocycline | LC-MS/MS | 25.000 ng/mL to 3000.000 ng/mL | EXP |
| 72 | Naproxen | LC-MS/MS | 1.000 µg/mL to 200.000 µg/mL | US |
| 73 | Nelfinavir | LC-MS/MS | For Nelfinavir: 25.000 ng/mL to 10000.000 ng/mL For Nelfinavir Hydroxy -T-Butylamide: 2.000 to 3000.000ng/mL | US |
| 74 | Nifedipine | LC-MS/MS | 0.500 to 500 ng/mL | EXP |
| 75 | Nimesulide | LC-MS/MS | 49.620 ng/mL to 5011.586 ng/mL | AN |
| 76 | Nisoldipine | LC-MS/MS | 0.200 ng/mL to 40.000 ng/mL | EXP |
| 77 | Nizatidine | LC-MS/MS | 25.062 ng/mL to 4009.920 ng/mL | US |
| 78 | Olenzapine | LC-MS/MS | 0.100 to 30.000ng/mL | - |
| 79 | Omeprazole | LC-MS/MS | 10.000 to 2000.000 ng/mL | UK/US |
| 80 | Oseltamivir | LC-MS/MS | 1.953 to 505.855 ng/mL | US |
| 81 | Oseltamivir + Oseltamivir Carboxylate | LC-MS/MS | For Oseltamivir: 1.953 to 505.855 ng/mL For Oseltamivir Carboxylate: 14.950 to 1510.135ng/mL | US |
| 82 | Oxcarbazepine | LC-MS/MS | For Oxcarbazepine: 50.000 ng/mL to 8000.000 ng/mL , For 10 Hydroxy Oxcarbazepine:150.000 ng/mL to 15000.000 ng/mL | EXP |
| 83 | Pantoprazole | LC-MS/MS | 50.000 ng/mL to 5000.000 ng/mL | UK |
| 84 | Paracetamol | LC-MS/MS | 100.000 ng/mLt0 20000.000ng/mL | UK |
| 85 | Progesterone | LC-MS/MS | 1 to 125ng/ml | - |
| 86 | Propranolol | LC-MS/MS | 1.000 to 500.000 ng/mL | UK |
| 87 | Propranolol & 4-Hydroxy Propranolol | LC-MS/MS | For Propranolol: 1.000ng/mL to 300.000ng/mL For 4-Hydroxy Propranolol: 0.200ng/mL to 50.000ng/mL | UK |
| 88 | Quinapril | LC-MS/MS | For Quinapril: 5.000 to 1000.0000ng/mL For Quinaprilate: 10.000 to 5000.000ng/mL | US |
| 89 | Rabeprazole | LC-MS/MS | 101.600 to 10160.000 ng/mL | - |
| 90 | Rabeprazole | LC-MS/MS | 5.000 ng/mL to 1000.000 ng/mL | EXP |
| 91 | Ranitidine | LC-MS/MS | 20.000 ng/mLto 3000.000ng/mL | US |
| 92 | Risperidone | LC-MS/MS | For Risperidone 0.501ng/mL to 30.035 ng/mL For 9-Hydroxy Risperidone: 0.502ng/mL to 30.106 ng/mL | EM |
| 93 | Risperidone | LC-MS/MS | For Risperidone 0.500ng/mL to 30.000 ng/mL For 9-Hydroxy Risperidone: 0.500ng/mL to 30.000 ng/mL | EXP |
| 94 | Secnidazole | HPLC | 0.200 to 50.000µg/mL | AN |
| 95 | Setraline | LC-MS/MS | 0.500 ng/mL to 110.000 ng/mL | UK |
| 96 | Sibutramine | LC-MS/MS | For Sibutramine: 0.500 to 50.000 ng/mL For Monomethyl Sibutramine: 0.500 to 50.000 ng/mL For Didesmethyl Sibutramine: 0.500 to 50.000 | UK |
| 97 | Simva + Rami | LC-MS/MS | For Sinvastatin 0.250ng/mL to 50.000 ng/mL For Simvastatin Acid: 0.250ng/mL to 50.000 ng/mL For Ramipril 0.250ng/mL to 40.000 ng/mL For Ra EXP |
| 98 | Simvastatin | LC-MS/MS | For Simvastatin: 0.250 ng/mL to 75.000 ng/Ml, For Simvastatin Acid:0.250 ng/mL to 50.000 ng/mL | UK |
| 99 | Simvastatin & Simvastatin Hydroxy Acid | LC-MS/MS | For Simvastatin: 0.500 to 75.000 ng/mL For Simvastatin Acid: 0.500 to 75.000 ng/mL | US |
| 100 | Stavudine | LC-MS/MS | 19.900 ng/mL to 1616.875 ng/mL | US |
| 101 | Stavudine+Lamivudine+Nevirapine | LC-MS/MS | For Stavudine: 20.000 ng/mL to 2000.000 ng/mL , For Lamivudine: 25.000 ng/mL to 3000.000 ng/mL , For Nevirapine: 50.000 ng/mL to 5000.000 ng/mL | WHO |
| 102 | Sumatriptan | LC-MS/MS | 2.000ng/mL to 200.000 ng/mL | EXP/UK |
| 103 | Topiramide | LC-MS/MSv | 4.955 to 2001.943 ng/mL | |
| 104 | Tramadol | LC-MS/MS | 5.000 ng/mL to 500.000 ng/mL | AN |
| 105 | Trimetazidine | LC-MS/MS | 1.5.00 ng/mL to 300.000 ng/mL | EXP |
| 106 | Tacrolimus | LC-MS/MS | 0.497 to 50.218 ng/mL | - |
| 107 | Topiramate | LC-MS/MS | 10.162 to 1016.236 ng/mL | US |
| 108 | UDCA+GDCA+TDCA | LC-MS/MS | For UDCA: 50.000 to 10000.000 ng/mL For GDCA: 100.000 to 10000.000 ng/mL For TDCA: 50.000 to 10000.000 ng/mL | - |
| 109 | Ursodiol | LC-MS/MS | 101.600 to 10160.000 ng/mL | - |
| 110 | Ursodiol +GDCA+TDCA | LC-MS/MS | For Ursodiol: 30.000 to 3000.000 ng/mL For GDCA: 30.000 to 3000.000 ng/mL For TDCA: 30.000 to 3000.000 ng/mL | - |
| 111 | Valproic Acid | LC-MS/MS | 2.000 ng/mL to 100.000 ng/mL | US |
| 112 | Valsartan | LC-MS/MS | 50.000 ng/mL to 10000.000 ng/mL | |
| 113 | Venlafaxine | LC-MS/MS | For Venlafaxine: 1.000 to 300.000 ng/mL For D-Venlafaxine: 2.000 to 300.000ng/mL | EXP/EM/UK/US |
| 114 | Venlafaxine | LC-MS/MS | For Venlafaxine: 0.998 to 100.818 ng/mL For D-Venlafaxine: 0.983 to 100.711 ng/mL | |
| 115 | Warfarin | LC-MS/MS | 50.000 ng/mLto 2000.000ng/mL | EM |
| 116 | Ziprasidone | LC-MS/MS | 0.500 to 300.000 ng/mL | US |
| 117 | Zolpidem | LC-MS/MS | 2.500 to 300.000ng/mL | US |
| 118 | Zopiclone | LC-MS/MS | For Zopiclone: 0.5.00 ng/mL to 150.000 ng/mL , For Zopiclone N- Oxide: 1.000 ng/mL to 150.000 ng/mL , For N-desmethyl zopiclone: 0.5.00 ng/mL to 150.000 ng/mL | UK |